Your browser doesn't support javascript.
loading
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Rai, Shinya; Kim, Won Seog; Ando, Kiyoshi; Choi, Ilseung; Izutsu, Koji; Tsukamoto, Norifumi; Maruyama, Dai; Tsukasaki, Kunihiro; Kuroda, Junya; Ando, Jun; Hidaka, Michihiro; Koh, Youngil; Kato, Hisashi; Uchida, Toshiki; Yang, Deok Hwan; Ishitsuka, Kenji; Ishizawa, Kenichi; Kim, Jin Seok; Lee, Hong Ghi; Minami, Hironobu; Eom, Hyeon Seok; Kurosawa, Mitsutoshi; Lee, Jae Hoon; Lee, Jong Seok; Lee, Won Sik; Nagai, Hirokazu; Shindo, Takero; Yoon, Dok Hyun; Yoshida, Shinichiro; Gillings, Mireille; Onogi, Hiroshi; Tobinai, Kensei.
Afiliação
  • Rai S; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama. rai@med.kindai.ac.jp.
  • Kim WS; Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul.
  • Ando K; Hematology and Oncology, Tokai University Hospital, Isehara.
  • Choi I; Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka.
  • Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo.
  • Tsukamoto N; Oncology Center, Gunma University Hospital, Maebashi.
  • Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo.
  • Tsukasaki K; Hematology, International Medical Center, Saitama Medical University, Saitama.
  • Kuroda J; Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto.
  • Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo.
  • Hidaka M; Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto.
  • Koh Y; Internal Medicine, Seoul National University Hospital, Seoul.
  • Kato H; Hematology and Oncology, Osaka University Graduate School of Medicine, Suita.
  • Uchida T; Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya.
  • Yang DH; Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Gwangju.
  • Ishitsuka K; Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima.
  • Ishizawa K; Third Internal Medicine, Yamagata University Hospital, Yamagata.
  • Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul.
  • Lee HG; Hematology and Oncology, Konkuk University Medical Center, Seoul.
  • Minami H; Medical Oncology/Hematology, Kobe University Hospital, Kobe.
  • Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang-si.
  • Kurosawa M; Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo.
  • Lee JH; Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon.
  • Lee JS; Division of Hematology-Oncology, Seoul National University Bundang Hospital, Gyeonggi.
  • Lee WS; Internal Medicine, Inje University Busan Paik Hospital, Busan.
  • Nagai H; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya.
  • Shindo T; Hematology and Oncology, Kyoto University Hospital, Kyoto.
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul.
  • Yoshida S; Hematology, National Hospital Organization Nagasaki Medical Center, Omura.
  • Gillings M; HUYABIO International, San Diego, CA.
  • Onogi H; Huya Japan GK, Tokyo.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo.
Haematologica ; 2024 Jun 06.
Article em En | MEDLINE | ID: mdl-38841789
ABSTRACT
Not available.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article